Healthy Habits, Maintain Lasting Results Tirzepatide offers a smarter, medically guided approach to weight management by supporting appetite control, metabolic health, and sustainable lifestyle changes
Easy Administration: Available in a 100ml sterile injection form, it can be administered intramuscularly or intravenously, with a recommended dosage of 3mL per 100kg of body weight
Appointments take longer due to travel and setup and fewer patients can be seen in a day
A ferritin test measures your iron levels
In the case of oral GLP-1 treatments, the factors known to complicate the process of establishing the optimal dosing regimen include: Bioavailability Taken orally, GLP-1 receptor agonists are exposed to significant acid in the stomach, resulting in enzymatic degradation
Liraglutide only activates the GLP-1 receptor, giving Tirzepatide more metabolic leverage Tirzepatide demonstrates superior HbA1c reduction and weight loss compared to Liraglutide across multiple network meta-analyses Tirzepatide reduced major adverse cardiovascular events (MACE) by 42% compared to Liraglutide in another large retrospective cohort analysis Both agents share similar safety profiles, but Tirzepatides dual mechanism delivers measurably better outcomes in most clinical endpoints How Tirzepatide and Liraglutide Work Differently Liraglutide is a single-target GLP-1 receptor agonist